Leroux, M E <br/><br/>
Sphingolipids and the sphingosine kinase inhibitor, SKI II, induce BCL-2-independent apoptosis in human prostatic adenocarcinoma cells.  [electronic resource] 

 -  The Prostate  Nov 2007 
 - 1699-717 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0270-4137 
<br/><br/><label>Standard No.: </label>10.1002/pros.20645  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Apoptosis--drug effects<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Ceramides--pharmacology<br/>Down-Regulation<br/>Enzyme Inhibitors--pharmacology<br/>Humans<br/>Male<br/>Phosphotransferases (Alcohol Group Acceptor)--antagonists & inhibitors<br/>Prostatic Neoplasms--drug therapy<br/>Proto-Oncogene Proteins c-bcl-2--metabolism<br/>Sphingosine--analogs & derivatives<br/>Thiazoles--pharmacology